GSK Ruling Raises Bar For Pharma On Brand Label Warnings
An Illinois federal court's finding that GlaxoSmithKline PLC didn't show that federal regulators would have rejected a warning that its antidepressant Paxil could make adult patients suicidal sets a high bar...To view the full article, register now.
Already a subscriber? Click here to view full article